SEC Form 4 · accession 0001144204-16-104532
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert W Schrepfer
Officer — VP Bus Dev & Con Mfg
Period of report
May 22, 2016
Accepted (ET)
May 24, 2016 · 4:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 22, 2016 | F | 450 | $49.54 | D | 29,862 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld by the Issuer to satisfy tax withholding obligation upon the vesting of 1,250 shares of restricted stock.